26th Feb 2003:      Medline: Clinical Effect of IFNb Not Proven Beyond 1 Year

26th Feb 2003:      Medline: Brain Volume and Lesion Load in RRMS

26th Feb 2003:      Medline: Review of Optimal Dose for IFNb in MS

26th Feb 2003:      Medline: Quality of Life in People with RRMS

26th Feb 2003:      Medline: Gabapentin in the Treatment of Tremor

26th Feb 2003:      Medline: Epidemiology of Urinary Tract Infections

26th Feb 2003:      Medline: Killer T Cells and PSGL-1 in PwMS

26th Feb 2003:      Medline: Neurotrophic Cross-Talk between Nervous and Immune System

26th Feb 2003:      Medline: Neurobehavioural Outcomes in People with TBI and MS

26th Feb 2003:      Medline: Gene Therapy Making alphaMSH to Treat EAE

26th Feb 2003:      Medline: Activation of NFkappaB and Pathogenesis of EAE

26th Feb 2003:      Medline: Risks of Peptide Immunotherapy in Animal Models of Diabetes and MS

26th Feb 2003:      Medline: Blocking RAGE Suppresses EAE

26th Feb 2003:      Medline: Acute Loss of Vision in Children

23rd Feb 2003:      Full Text: Therapeutic Potential of PPARs for Neurologic Disease

23rd Feb 2003:      Evidence for Long-Term Benefit of Interferons in MS?

23rd Feb 2003:      Interferon Treatment of MS Questioned (The Lancet Article)

23rd Feb 2003:      DGReview of Lancet Interferon Article

23rd Feb 2003:      MS Drugs Scheme a Waste of Money? (The BMJ Article)

23rd Feb 2003:      That BMJ Article again!

23rd Feb 2003:      MS Trust Comments on BMJ Article

23rd Feb 2003:      Professional Response to BMJ Article

23rd Feb 2003:      UK Government Rejects Criticism of Drugs Scheme

23rd Feb 2003:      Delays in MS Drugs Scheme

23rd Feb 2003:      More on UK MS Drug Delays

23rd Feb 2003:      Neuroimmunology of Mood Disorders and MS

23rd Feb 2003:      Introduction to Immunomodulation

23rd Feb 2003:      MS in Children

23rd Feb 2003:      Researchers Investigate MS Genetic Factors

23rd Feb 2003:      Inflammation may be Root of Diseases

23rd Feb 2003:      Queens and US Researchers to Investigate MS

23rd Feb 2003:      Possible HHV-6 MS Link

23rd Feb 2003:      IVIg Trial

23rd Feb 2003:      Abbott Laboratories Monoclonal Antibody Trial with MS

23rd Feb 2003:      Peptide Immunotherapy Treatment Questioned

23rd Feb 2003:      Pharmos Trial of Cannabinoid for TBI

23rd Feb 2003:      Germany Seeks Global Cloning Ban Through UN

23rd Feb 2003:      Cord Blood Claims Questioned

23rd Feb 2003:      Improved Supply of Med MJ Needed

23rd Feb 2003:      UK Disability Rights Commission Say Equality Plans Won't Work

23rd Feb 2003:      UK MSS Palliative Care for People with Severe MS

23rd Feb 2003:      UK Draft Guidance on Disabled Facilities Grant

23rd Feb 2003:      UK MSS Alert to More Interactivity

23rd Feb 2003:      Cannabis on the NHS

23rd Feb 2003:      Med MJ/Montana

23rd Feb 2003:      Cowboy to Hang Up His Hat

23rd Feb 2003:      Woman w/MS - ServiceDog

23rd Feb 2003:      Modifications for Work and Home

23rd Feb 2003:      Care for Caregivers

23rd Feb 2003:      Waiting for MS Drug

23rd Feb 2003:      UK Mother MS Drug Delay

23rd Feb 2003:      What Is MS?

23rd Feb 2003:      Mouth Painter w/MS

23rd Feb 2003:      Man w/MS

23rd Feb 2003:      Jimmy Heuga Snow Express

20th Feb 2003:      Full Text: Criticising UK NHS Risk Sharing Scheme

20th Feb 2003:      Medline: Dealing with Progressive MS

20th Feb 2003:      Medline: 4 Year Study of Disease Management in MS

20th Feb 2003:      Medline: Attitudes to Long-term Care in MS

20th Feb 2003:      Medline: Psychosocial Aspects of MS

20th Feb 2003:      Medline: Deciding on Treatment in MS

20th Feb 2003:      Medline: Comparing Rebif with Betaseron

20th Feb 2003:      Medline: Intention Tremor Rated and Different Finger to Nose Tests

20th Feb 2003:      Medline: Comparison of Mechanisms of IFN-b and Copaxone

20th Feb 2003:      Medline: Reactive Astrocytes in Chronic Active MS Lesions

20th Feb 2003:      Medline: Pain Rehabilitation and Sensory Spasticity

20th Feb 2003:      Medline: Polyunsaturated Fatty Acids and Pathological Pain

20th Feb 2003:      Medline: MS-Associated Virus More Common in PwMS

20th Feb 2003:      Medline: Radiotherapy and MS Relapses

20th Feb 2003:      Medline: High-Dose Cyclophosphamide, ASCT and MS

20th Feb 2003:      Medline: Study of Bushen Gusui for MS

20th Feb 2003:      Medline: IFN-b for MS in Saudi Arabia

20th Feb 2003:      Medline: Clinical Evaluation of MS

20th Feb 2003:      Medline: 3D MRI Data for MS Clinical Trials

20th Feb 2003:      Medline: CSF Changes After IV Gadolinium

20th Feb 2003:      Medline: Protection of Mature Oligodendrocytes

20th Feb 2003:      Medline: Trial of Glutamine Supplementation for ASCT

20th Feb 2003:      Medline: Accuracy and Reproducibility of MS MRIs

20th Feb 2003:      Medline: HHV6 DNAaemia in PwMS

20th Feb 2003:      Medline: Brain MRI Lesion Load in MS

20th Feb 2003:      Medline: IFN-b and Clinical Thyroid Dysfunction in MS

20th Feb 2003:      Medline: Autoimmune Neutropenia Associated with MS

20th Feb 2003:      Medline: MS-Associated Retrovirus and T Cell Death in EAE

20th Feb 2003:      Medline: Th2 Bias in CD4 NKT Cells During Remission

20th Feb 2003:      Medline: ICAM-1 Polymorphism and MS

20th Feb 2003:      Medline: CNP1 and Oligodendrocyte Functions in Myelination

20th Feb 2003:      Medline: Anti-MOG B Cell Responses in MS

20th Feb 2003:      Medline: T2 Relaxation Time Histograms in MS

20th Feb 2003:      Medline: Upregulation of Apoptosis Regulators in RRMS

20th Feb 2003:      Medline: NFkappaB and AP-1 DNA Binding in PwMS

20th Feb 2003:      Medline: Immunologic Endocrine Disorders

20th Feb 2003:      Medline: HSP70 Associations with MBP and PLP in MS

20th Feb 2003:      Medline: Dendritic Cells and CNS Inflammation

20th Feb 2003:      Medline: Secondary Lymphoid Organ Chemokines and CNS Inflammation

20th Feb 2003:      Medline: Immunologic Neuromuscular Disorders

20th Feb 2003:      Medline: Ingested Type-I Interferon for Autoimmunity

20th Feb 2003:      Medline: Lymphoid Chemokines CCL19 and CCL21 Expression in EAE

20th Feb 2003:      Medline: Upregulation of Group1 CD1 Antigen Presenting Molecules in EAE

20th Feb 2003:      Medline: MOG Peptides and T Cells in EAE

20th Feb 2003:      Medline: Autoimmune Demyelination in EAE

20th Feb 2003:      Medline: Pro Apoptotic Protein, P53, and EAE

12th Feb 2003:      UK Trials of ATL1102 for MS

12th Feb 2003:      More on ATL1102

12th Feb 2003:      Clue to Viral Trigger in MS

12th Feb 2003:      Relationship Functioning and Sexuality in PwMS

12th Feb 2003:      Correlations Between Clinical Findings and MRI in MS

12th Feb 2003:      Normal Appearing Grey Matter in PPMS

12th Feb 2003:      Avonex Side-Effect Warning

12th Feb 2003:      FDA Approves Avonex for Early MS Treatment

12th Feb 2003:      NMSS on Avonex Label Change

12th Feb 2003:      Immune System's Dark Side

12th Feb 2003:      Recommendations Concerning Methylprednisolone Shortage

12th Feb 2003:      New Pill to Rival Viagra in UK and Germany

12th Feb 2003:      Full Text: IVIg, Carbamazepine and Trigeminal Neuralgia

12th Feb 2003:      Talking About Your MS - Part 1

12th Feb 2003:      Talking About Your MS - Part 2

12th Feb 2003:      Current Status of UK MS Therapies Risk Sharing Scheme

12th Feb 2003:      Half of UK Nurses Back Assisted Suicide

12th Feb 2003:      Australian Internet Miracle Water Scam

12th Feb 2003:      Rival Cloning Bills Introduced in US Congress

12th Feb 2003:      US Congress Again Backs Cloning Ban Bill

12th Feb 2003:      Biogen Ordered to Pay Schering $55 million

12th Feb 2003:      More on Med MJ in Canada

12th Feb 2003:      MS in Focus

12th Feb 2003:      Novel Featuring Woman w/MS

12th Feb 2003:      Customized Genetic Profile to Predict Health

12th Feb 2003:      Living with Mom's MS

12th Feb 2003:      Making a List - Checking It Twice

12th Feb 2003:      The Phone Call

12th Feb 2003:      Move It!

12th Feb 2003:      Pump It Up!

12th Feb 2003:      Conversation About Disabilities

12th Feb 2003:      Health Educator w/MS

12th Feb 2003:      Olympic Cyclist w/MS

12th Feb 2003:      More On Kelly Sutton

12th Feb 2003:      More On Alastair Hignell

12th Feb 2003:      Woman w/MS - Medically Needy Program

12th Feb 2003:      Woman w/MS - Financial Problems

12th Feb 2003:      Church Nursing Home Inspired by PwMS

8th Feb 2003:        Medline: Ambient Air Quality and MS Relapses

8th Feb 2003:        Medline: Radon - Possible Risk Factor in MS

8th Feb 2003:        Medline: Lip and Tongue Function Differently Affected in PwMS

8th Feb 2003:        Medline: MS in Canada from 1965 to 1994

8th Feb 2003:        Medline: Standardized Incidence and Prevalence Rates in MS

8th Feb 2003:        Medline: MS in Jewish and Arab Populations in Jerusalem

8th Feb 2003:        Medline: Axonal Loss and MS Progression

8th Feb 2003:        Medline: Axonal Damage is Predictor of Outcome in CNS Diseases

8th Feb 2003:        Medline: Primary and Secondary Progressive MS

8th Feb 2003:        Medline: The Diagnosis of PPMS

8th Feb 2003:        Medline: Prognostic Factors for Progression of Disability in SPMS

8th Feb 2003:        Medline: Hypoxia Like Tissue Injury in MS Lesions

8th Feb 2003:        Medline: MRI and Clinical Correlations in PPMS

8th Feb 2003:        Medline: More on MRI-Clinical Correlations in MS

8th Feb 2003:        Medline: MRI of Short T2 Components in Tissue

8th Feb 2003:        Medline: Remyelination in Multiple Sclerosis

8th Feb 2003:        Medline: Meningeal Cells Enhance Limited CNS Remyelination

8th Feb 2003:        Medline: Disease Modifying Therapy in RRMS

8th Feb 2003:        Medline: Mitoxantrone in Progressive MS

8th Feb 2003:        Medline: Ablative Immunotherapy with Monoclonal Antibodies and/or ASCT

8th Feb 2003:        Medline: IVIg Regulating Autoreactive T Cells in MS

8th Feb 2003:        Medline: IVIg in Treatment of MS

8th Feb 2003:        Medline: IFNb Does Not Always Slow Axonal Injury in MS

8th Feb 2003:        Medline: Interferon Beta and MultipleSclerosis

8th Feb 2003:        Medline: Once Weekly IFNb Superceded by More Frequent Dosing

8th Feb 2003:        Medline: Early Use of IFNb in PwMS

8th Feb 2003:        Medline: IFNb-1a for SPMS

8th Feb 2003:        Medline: IFNb-1a in PPMS

8th Feb 2003:        Medline: Case Study - Adverse Psychiatric Side Effects of IFNb-1a for MS

8th Feb 2003:        Medline: Copaxone, IL-10, IL-12 and MS

8th Feb 2003:        Medline: Elavated IL-15 in RRMS

8th Feb 2003:        Medline: Low IL-10 Production Associated with Higher Disability in SPMS

8th Feb 2003:        Medline: TNF-alpha and -beta Gene Polymorphisms in MS

8th Feb 2003:        Medline: Monocyte Derived Cytokines in MS

8th Feb 2003:        Medline: Prolactin and Prolactin Receptor Genes in MS and SLE

8th Feb 2003:        Medline: Augmentation Cystoplasty in PwMS

8th Feb 2003:        Medline: Side-Chain Oxidised Oxysterols in CSF and BBB

8th Feb 2003:        Medline: Immune Modulation by Plasmid DNA Mediated Cytokine Gene Transfer

8th Feb 2003:        Medline: Mast Cell fc Receptors Regulate EAE Severity

8th Feb 2003:        Medline: Retroviral Gene Transfer by Stem Cells Exacerbates EAE

8th Feb 2003:        Medline: LF 15-0195 Inhibits CNS Autoimmunity in Rats

8th Feb 2003:        Medline: DNA Vaccination for EAE

8th Feb 2003:        Medline: Neuropathology of EAE Modified by Retroviral Infection

8th Feb 2003:        Medline: Epitope Spreading Not Required for Relapses in EAE

8th Feb 2003:        Medline: EAE in IL-12 Receptor beta2 Deficient Mice

8th Feb 2003:        Medline: Treatment of Spasticity with Botulinum Toxin

8th Feb 2003:        Medline: Killer T Cells as Targets for Autoimmune Disease Therapy

8th Feb 2003:        Medline: G Protein Coupled A2a Adenosine Receptors And Inflammation

8th Feb 2003:        Medline: Acute Disseminated Encephalomyelitis

8th Feb 2003:        Medline: ICOS Costimulation in IBD

8th Feb 2003:        Medline: More on IBD

8th Feb 2003:        Medline: Childhood Inflammatory Demyelinating Polyneuropathy Resembles MS

8th Feb 2003:        Medline: Chiari Type-I Malformation

8th Feb 2003:        Medline: HTLV-1